3G9 IgG and Fc:TβRII have similar molecular weights and structures and it is unlikely that the difference in sensitivity to 3G9 IgG and Fc:TβRII can be attributed to disparities in the uptake and distribution in the carcinoma tissue. This evidence concerns the gene TGFBR2 and carcinoma.